The complaint device was received with the original unopened packaging.The lot number was verified from the packaging label.The product was observed to have a tear in the packaging's poly material adjacent to the product device's injection port cap.This resulted in an opening in the packaging material and therefore the product's sterility was breached.Due to the location and appearance of the defect area it is likely that the device caused the damaged to the packaging.The manufacturing documents from the device history record have been reviewed with special attention to the manufacturing and inspection of the product.The products released for distribution were found to have met all specifications prior to shipment.Of the lot containing (b)(4) units, no prior complaints have been received for this failure mode.A two-year history complaint review revealed one similar complaint involving sixteen devices for this device family and failure mode.In this same timeframe, (b)(4) units have been manufactured and sold worldwide.The failure rate for this device family and failure mode, should all complaints have been confirmed, would be (b)(4).A risk analysis was performed and this failure was found to be acceptable.This reported packaging issue was obvious to the distributor, prompting the return of the device for evaluation.There was no patient involvement.As with all medical devices, examination of the product occurs multiple times prior to use.Good clinical practice would include examination and verification of the original packaging and its labeling to ensure both are intact.Per the ifu for this device, the user is advised: - inspect the device for damage and if damage is found to discard the device.This incident type will continue to be monitored through the complaint system to assure patient safety.
|